Skip to main content
Livermore
Livermore
ZHEN

Ensysce Biosciences, Inc.

ENSC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001716947

In the last 90 days, Ensysce Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $261.1K in total; no superinvestor holds it.

Holders of 5% or more of ENSC

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ensysce Biosciences, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ENSC
HolderLatest formStakeChangeFirst filedLatest filingFiling
Gower Bob G13D/A6.10%1.21M shares–Jul 12, 20213 filingsAug 18, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

32 Schedule 13D and 13G filings on Ensysce Biosciences, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ENSC
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 18, 202612:30 PM ETGower Bob G13D/A6.10%1.21M shares–Aug 7, 2026SEC
Aug 12, 20259:03 AM ETAdage Capital Management, L.P.and 2 others13G/A3.15%74.7K shares−2.17 ppfrom 5.32%Below 5%Jun 30, 2025SEC
May 15, 20254:30 PM ETPerceptive Advisors LLCand 2 others13G/A3.70%86.7K shares−1.60 ppfrom 5.30%Below 5%Mar 31, 2025SEC
May 12, 20259:03 AM ETAdage Capital Management, L.P.and 2 others13G5.32%74.7K sharesNewMar 31, 2025SEC
Apr 3, 20254:18 PM ETPerceptive Advisors LLCand 2 others13G/A5.30%86.7K shares+4.90 ppfrom 0.40%Mar 31, 2025SEC
Feb 14, 20256:34 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 14, 20255:22 PM ETAnson Funds Management LPand 5 others13G/A2.10%411.7K shares–Below 5%Dec 31, 2024SEC
Feb 14, 20254:15 PM ETPerceptive Advisors LLCand 2 others13G/A0.40%86.7K shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024Anson Funds Management LP13GOld format–New–SEC
Nov 6, 2024Ra Capital Management, L.P.13GOld format–New–SEC
Oct 29, 2024Perceptive Advisors LLC13GOld format–New–SEC
Feb 14, 2024Lincoln Park Capital Fund, LLC13G/AOld format–––SEC
Jul 18, 2023Gower Bob G13D/AOld format–––SEC
Feb 14, 2023HG Vora Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2023CVI Investments, Inc.13G/AOld format–––SEC
Feb 7, 2023Lincoln Park Capital Fund, LLC13GOld format–New–SEC
Dec 16, 2022CVI Investments, Inc.13GOld format–New–SEC
Jul 7, 2022Silvers Daniel B.13D/AOld format–––SEC
Feb 14, 2022HG Vora Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2022Glazer Capital, LLC13G/AOld format–––SEC
Oct 12, 2021Silvers Daniel B.13D/AOld format–––SEC
Jul 12, 2021Wright Richard Chester13DOld format–New–SEC
Jul 12, 2021Chang William H13DOld format–New–SEC
Jul 12, 2021Gower Bob G13DOld format–New–SEC
Jul 12, 2021Kirkpatrick Lynn13DOld format–New–SEC
Jul 7, 2021Hydra LAC, LLC13G/AOld format–––SEC
Jul 6, 2021Silvers Daniel B.13DOld format–New–SEC
Feb 16, 2021Glazer Capital, LLC13G/AOld format–––SEC
Feb 12, 20213:25 PM ETBank of Montreal13G/AOld format–––SEC
Feb 11, 2021Weiss Asset Management LP13G/AOld format–––SEC
Feb 10, 2021MLCP GLL Funding LLC13GOld format–New–SEC
Feb 10, 2021Hydra LAC, LLC13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Ensysce Biosciences, Inc. shares.

No Form 144 notices for Ensysce Biosciences, Inc. are on file.